TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$5.02
Tradestie Score
45
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+165.6%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.60
|
$1.81B | - | 33 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$10.89
|
$1.78B | - | 41 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.21
|
$1.78B | - | 45 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$127.22
|
$1.77B | - | 46 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$21.24
|
$1.74B | - | 44 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$36.90
|
$1.68B | - | 45 | Compare |
|
MNKD
Mannkind Corporation
|
$3.75
|
$1.65B | - | 37 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.40
|
$1.63B | - | 52 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.71
|
$1.57B | - | 48 | Compare |
|
VCEL
Vericel Corporation
|
$38.34
|
$1.56B | 80.6 | 51 | Compare |
More TSHA Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry